AI breakthrough may lead to highly personalized medicine in the treatment of serious diseases

By: Media Relations

Machine learning is now helping researchers analyze the makeup of unfamiliar cells, which could lead to more personalized medicine in the treatment of cancer and other serious diseases.  

Researchers at the University of Waterloo developed GraphNovo, a new program that provides a more accurate understanding of the peptide sequences in cells. Peptides are chains of amino acids within cells and are building blocks as important and unique as DNA or RNA.

In a healthy person, the immune system can correctly identify the peptides of irregular or foreign cells, such as cancer cells or harmful bacteria, and then target those cells for destruction. For people whose immune system is struggling, the promising field of immunotherapy is working to retrain their immune systems to identify these dangerous invaders.

Read the full article from Waterloo News to learn more.